AAAAAA
Results:
1-7
|
Results: 7
Development of proteo-chemometrics: a novel technology for the analysis ofdrug-receptor interactions
Authors:
Lapinsh, M
Prusis, P
Gutcaits, A
Lundstedt, T
Wikberg, JES
Citation: M. Lapinsh et al., Development of proteo-chemometrics: a novel technology for the analysis ofdrug-receptor interactions, BBA-GEN SUB, 1525(1-2), 2001, pp. 180-190
Authors:
Prusis, P
Muceniece, R
Mutule, I
Mutulis, F
Wikberg, JES
Citation: P. Prusis et al., Design of new small, cyclic melanocortin receptor-binding peptides using molecular modelling: Role of the His residue in the melanocortin peptide core, EUR J MED C, 36(2), 2001, pp. 137-146
Authors:
Muceniece, R
Mutule, I
Mutulis, F
Prusis, P
Szardenings, M
Wikberg, JES
Citation: R. Muceniece et al., Detection of regions in the MC1 receptor of importance for the selectivityof the MC1 receptor super-selective MS04/MS05 peptides, BBA-PROT ST, 1544(1-2), 2001, pp. 278-282
Authors:
Prusis, P
Muceniece, R
Andersson, P
Post, C
Lundstedt, T
Wikberg, JES
Citation: P. Prusis et al., PLS modeling of chimeric MS04/MSH-peptide and MC1/MC3-receptor interactions reveals a novel method for the analysis of ligand-receptor interactions, BBA-PROT ST, 1544(1-2), 2001, pp. 350-357
Authors:
Wikberg, JES
Muceniece, R
Mandrika, I
Prusis, P
Lindblom, J
Post, C
Skottner, A
Citation: Jes. Wikberg et al., New aspects on the melanocortins and their receptors, PHARMAC RES, 42(5), 2000, pp. 393-420
Authors:
Schioth, HB
Prusis, P
Muceniece, R
Mutulis, F
Mutule, I
Wikberg, JES
Citation: Hb. Schioth et al., Thyrotropin releasing hormone (TRH) selectively binds and activates the melanocortin 1 receptor, PEPTIDES, 20(3), 1999, pp. 395-400
Authors:
Skuladottir, GV
Jonsson, L
Skarphedinsson, JO
Mutulis, F
Muceniece, R
Raine, A
Mutule, I
Helgason, J
Prusis, P
Wikberg, JES
Schioth, HB
Citation: Gv. Skuladottir et al., Long term orexigenic effect of a novel melanocortin 4 receptor selective antagonist, BR J PHARM, 126(1), 1999, pp. 27-34
Risultati:
1-7
|